|本期目录/Table of Contents|

[1]彭小乐 郭 东 林佳鹤 胡小强 靳凯悦 王建云.S-腺苷甲硫氨酸抑制miR-34a依赖的肺癌转移的作用[J].中华肺部疾病杂志,2021,(02):184-188.[doi:10.3877/cma.j.issn.1674-6902.2021.02.010]
　Peng Xiaole,Guo Dong,Lin Jiahe,et al.Role of S-adenosylmethionine in suppressing mir-34a dependent lung cancer metastasis[J].,2021,(02):184-188.[doi:10.3877/cma.j.issn.1674-6902.2021.02.010]
点击复制

S-腺苷甲硫氨酸抑制miR-34a依赖的肺癌转移的作用(PDF)

《中华肺部疾病杂志》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2021年02期
页码:
184-188
栏目:
论著
出版日期:
2021-04-20

文章信息/Info

Title:
Role of S-adenosylmethionine in suppressing mir-34a dependent lung cancer metastasis
作者:
彭小乐1 郭 东2 林佳鹤3 胡小强1 靳凯悦1 王建云1
101200 北京,首都医科大学附属北京友谊医院平谷医院心胸外科1、麻醉科3 101200 北京,北京安贞医院心外科2
Author(s):
Peng Xiaole1;  Guo Dong2;  Lin Jiahe3;  Hu Xiaoqiang1;  Jin Kaiyue1;  Wang Jianyun1.
1Department of Cardiothoracic Surgery, 3 Department of Anesthesiology, Pinggu Hospital, Beijing Friendship Hospital, Capital Medical University, Beijing 101200, China; 2Department of Cardiac Surgery, Beijing Anzhen Hospital, Beijing 101200, China
关键词:
支气管肺癌;  S-腺苷甲硫氨酸;  miR-34a;  癌症转移
Keywords:
Bronchogenic carcinoma;  SAMe;  MiR-34a;  Cancer metastasis
分类号:
R734.2
DOI:
10.3877/cma.j.issn.1674-6902.2021.02.010
摘要:
目的 探讨S-腺苷甲硫氨酸抑制miRNA-34a依赖的肺癌转移机制。方法 选取肺癌细胞A549,分别采用0、50、100、200、500 μM的S-腺苷甲硫氨酸(S-adenosylmethionine, SAMe)刺激A549细胞并检测miR-34a以及下游STAT3信号通路的表达情况,同时检测不同刺激条件下A549细胞的侵袭转移情况; 实时荧光定量(real-time fluorescence quantification, qPCR)检测miR-34a、E-cadherin、α-catenin、N-cadherin、Vimentin的mRNA表达水平; Western Blot实验检测STAT3、p-STAT3、β-actin的表达水平; Transwell实验检测A549细胞的侵袭能力变化。结果 随着SAMe浓度的增加,miR-34a的表达水平呈梯度增加,与对照组相比,经t检验分析,差异有统计学的意义(P<0.05); Western Blot实验显示,与对照组相比,500 μM SAMe刺激后,下游的p-STAT3蛋白水平下降,总STAT3和内参蛋白β-actin水平不变; qPCR结果显示,随着药物浓度的增加,表皮蛋白E-cadherin、α-catenin 的mRNA水平上升,间质蛋白N-cadherin、Vimentin的mRNA水平下降; Transwell实验显示经50、100、200、500 μM 的SAMe刺激后,A549细胞的侵袭转移抑制率分别为18.70%、31.24%、47.66%、58.46%,与对照组相比,经t检验分析,差异有统计学的意义(P<0.05)。 结论 SAMe可通过抑制miR-34a依赖的下游STAT3信号通路抑制肺癌细胞的侵袭转移,提示SAMe在肺癌侵袭转移过程中发挥重要作用。
Abstract:
Objective To investigate the molecular mechanisms of S-adenosine methionine in suppressing lung cancer metastasis with a miRNA-34a-dependent manner. Methods A549 lung cancer cell was selected as the study model of this time research. A549 cells were stimulated with 0, 50, 100, 200, 500 μM SAMe, respectively and the expression of miR-34a and its related STAT3 signaling pathways were also detected. The invasive capacity of cells was detected under various condition as well; miR-34a, E-cadherin, α-catenin, N-cadherin and Vimentin mRNA expression were detected by qPCR method; Western Blot was used to detect expression of STAT3, p-STAT3 and β-actin; Invasive capacity of A549 cells was detected by Transwell experiment. Results As the increase of SAMe concentration, miR-34a expression increased gradually, and when it was compared to the control group, the difference was statistically significant through the t-test(P<0.05); Western Blot experiments showed that p-STAT3 protein level of 500 μM SAMe stimulation was lower than 0 μM treatment, while total STAT3 and β-actin level had no change; q-PCR results showed that E-cadherin and α-catenin level elevated, but N-cadherin and Vimentin level decreased as the increase of drug concentration; Transwell experiments showed that invasive inhibitory rates of A549 cells in 50, 100, 200, 500 μM of SAMe were 18.70%, 31.24%, 47.66% and 58.46%, respectively. And compared to the control group, the difference had statistical significance by t-tset(P<0.05). Conclusion SAMe could suppress cell metastasis through a miR-34a-dependent manner by inhibiting STAT3 signaling pathway in lung cancer cells, which suggested a potential role of SAMe in metastasis of lung cancer.

参考文献/References:

1 钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
2 任成山, 白 莉, 钱桂生. 慢性阻塞性肺疾病合并肺癌临床特征及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(2): 137-142.
3 赵邱煜, 信 涛. 非小细胞肺癌脑膜转移治疗的研究进展[J]. 医学综述, 2021, 27(02):303-307.
4 Hoffman PC, Mauer AM, Vokes EE. Lung cancer[J]. Lancet, 2000, 355(9202): 479-85.
5 Yoder LH. Lung cancer epidemiology[J]. Medsurg Nurs, 2006, 15(3): 171-174.
6 Chen W, Zheng R, Zeng H, et al. Epidemiology of lung cancer in China[J]. Thorac Cancer, 2015, 6(2): 209-15.
7 Keshamouni V, Arenberg D, Kalemkerian G. Lung Cancer Metastasis[M]. 2010.
8 茆春国, 邓 波. 肺癌循环肿瘤细胞侵袭转移机制的研究进展[J].中国肺癌杂志, 2020, 23(03): 189-195.
9 朱 丽, 龚 波. 下调miR-4262抑制肺癌细胞A549转移潜能的机制[J].分子诊断与治疗杂志, 2020, 12(10): 1375-1379.
10 郭梦玲, 王熙才, 陈 艳. 外泌体miRNA与肺癌的发生发展[J]. 中国肿瘤生物治疗杂志, 2020, 27(04): 457-462.
11 余昌敏, 张 丹, 闵 明, 等. 外泌体miRNA作为癌症早期诊断标志物的研究进展[J]. 中国免疫学杂志, 2020, 36(22): 2786-2790.
12 Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks[J]. Nature cell biology, 2013, 15(6): 546-554.
13 Tang Y, Tang Y, Cheng YS. miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway[J]. Sci Rep, 2017, 7: 38232.
14 张月朋, 陈复辉. miR-34在非小细胞肺癌中研究进展[J]. 中华实用诊断与治疗杂志, 2020, 34(06): 643-645.
15 刘 罡, 毛重山. miR-34a靶向CD44对肺癌细胞干细胞表型的影响[J]. 中国老年学杂志, 2019, 39(10): 2477-2480.
16 王鑫元, 国 强, 常哲瀚, 等. 奥沙利铂通过调控P53、miR-34a抑制胃癌细胞的增殖[J]. 包头医学院学报, 2020, 36(10): 67-70+121.
17 Li XJ, Zhang W, Xu K, et al. miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway[J]. Pathol Res Pract, 2020,216(5): 152876.
18 梁 辰, 王 萍, 金由辛, 等. p53/miR-34a调控网络在肿瘤中的作用[J]. 生命科学, 2016, 28(04): 464-469.
19 Zhu H, Chang LL, Yan FJ, et al. AKR1C1 activates STAT3 to promote the metastasis of non-small cell lung cancer[J]. Theranostics, 2018, 8(3): 676-92.
20 Wang AS, Duan GX, Zhao CL, et al. Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation[J]. Oncol Lett, 2017, 13(5): 3039-3045.
21 茹泽园. 肺癌细胞外泌体通过其携带的IL-6介导的STAT3途径诱导肌管萎缩的机制研究[D]. 华中科技大学, 2019.
22 Chiang PK, Gordon RK, TAL J, et al. S-Adenosylmethionine and methylation[J]. Faseb J, 1996, 10(4): 471-480.
23 刘绍文. S-腺苷甲硫氨酸(SAMe)对人肝内胆管癌细胞系ICC-9810增殖及迁移能力的影响及作用机制[D]. 皖南医学院, 2019.
24 Palmisano WA. DNA methylation markers and early recurrence in stage i lung cancer[J]. N Engl J Med, 2008, 358(11): 1118-1128.
25 孙东峰, 田 辉, 刘贤锡, 等. 鸟氨酸脱羧酶和S-腺苷甲硫氨酸脱羧酶双反义腺病毒对肺癌增殖和侵袭抑制作用的研究[J]. 中华外科杂志, 2008, 46(1): 61-64.
26 Torre LA, Siegel RL, Jemal A. Lung cancer statistics[J]. Adv Exp Med Biol, 2016, 893: 1-19.
27 Faure M. Lung cancer in Europe: turning the spotlight on the biggest cancer killer[J]. Eur Respir J, 2016, 47(1): 42-4.
28 范 伟. S-腺苷甲硫氨酸抑制非小细胞性肺癌增殖,侵袭,转移的机制[D]. 广州医科大学, 2018.
29 宋伟祥, 卢 伟. 腺苷蛋氨酸在肠癌肝转移患者化疗期间的护肝作用[J]. 肿瘤研究与临床, 2011(12): 847-848.
30 刘 敏. S-腺苷甲硫氨酸脱羧酶基因表达与大肠癌关系的研究[D]. 山东大学, 2006.
31 Zhang F, Wang B, Qin T, et al. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation[J]. Mol Cell Biochem, 2020, 473(1-2): 1-3.
32 Rokavec M, Oner MG, Li H, et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis[J]. J Clin Invest, 2014, 124(4): 1853-1867.

备注/Memo

备注/Memo:
基金项目: 北京市医院管理局“登峰”计划专项经费资助(DFL20180602)
通信作者: 王建云, Email: wangjianyun1805@sina.com
更新日期/Last Update: 2021-04-20